Study guide
11.5 Vitamin K, Eye Prophylaxis, Immunization & Routine Neonatal Medications
NCC Low Risk Neonatal Nursing RNC-LRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Maternal-Fetal Risk Assessment
1.1 RNC-LRN Exam Structure, Eligibility & Test Blueprint 1.2 Maternal Health Conditions & Prenatal Risk Factors 1.3 Intrapartum Events & Fetal Surveillance Interpretation 1.4 Antepartum Fetal Surveillance, Labor Progression & Perinatal Screening
2 Chapter 2: Comprehensive Neonatal Assessment & Gestational Age
2.1 Physical Assessment & Normal Variations vs. Abnormalities 2.2 Gestational Age Assessment: New Ballard Score & Maturity Classification 2.3 Neurobehavioral Assessment & Primitive Reflexes
3 Chapter 3: Neonatal Diagnostic & Laboratory Evaluation
3.1 Neonatal Blood Gas Interpretation & Acid-Base Balance 3.2 Hematologic & Metabolic Laboratory Diagnostics 3.3 Newborn Screening & Diagnostic Imaging Modalities
4 Chapter 4: Neonatal Respiratory Pathophysiology & Management
4.1 Respiratory Distress Syndrome (RDS) & Surfactant Deficiency 4.2 Transient Tachypnea of the Newborn (TTN) 4.3 Meconium Aspiration Syndrome (MAS) & Air Leaks 4.4 Apnea of Prematurity (AOP) & Persistent Pulmonary Hypertension (PPHN) 4.5 Oxygenation Assessment & Non-Invasive Respiratory Support
5 Chapter 5: Neonatal Cardiovascular Conditions & Hemodynamics
5.1 Fetal-to-Neonatal Circulatory Transition & Innocent Murmurs 5.2 Patent Ductus Arteriosus (PDA) & Ductal-Dependent Cardiac Lesions 5.3 Congenital Heart Defects & CCHD Pulse Oximetry Screening
6 Chapter 6: Neurologic & Gastrointestinal/Genitourinary Disorders
6.1 Hypoxic-Ischemic Encephalopathy (HIE) & Therapeutic Hypothermia 6.2 Neonatal Seizures & Intraventricular Hemorrhage (IVH) 6.3 Gastrointestinal Pathologies & Necrotizing Enterocolitis (NEC) 6.4 Congenital GI/GU Anomalies & Renal Function
7 Chapter 7: Hematology, Hyperbilirubinemia, and Genetic/Endocrine Conditions
7.1 Neonatal Hyperbilirubinemia & Kernicterus Risk 7.2 Hemolytic Disease & Neonatal Hematologic Disorders 7.3 Inborn Errors of Metabolism & Endocrine Disorders 7.4 Infant of a Diabetic Mother (IDM) & Chromosomal Anomalies
8 Chapter 8: Resuscitation & Immediate Neonatal Stabilization
8.1 Neonatal Resuscitation Program (NRP) 9th Edition Core Algorithm 8.2 Advanced Resuscitation: Chest Compressions & Emergency Medications 8.3 Post-Resuscitation Stabilization & The S.T.A.B.L.E. Framework
9 Chapter 9: Nutrition, Feeding & Gastrointestinal Support
9.1 Maternal Breast Milk, Lactation Support & Donor Milk 9.2 Nutritional Fortification & Specialized Formula Selection 9.3 Enteral Feeding Methods, Trophic Feeds & Gavage Administration
10 Chapter 10: Thermoregulation, Fluids, Electrolytes & Glucose Management
10.1 Thermoregulation & Prevention of Cold Stress 10.2 Fluid Requirements & Electrolyte Management 10.3 Neonatal Hypoglycemia Assessment & Management Protocols
11 Chapter 11: Infection Control, Sepsis & Neonatal Pharmacology
11.1 Early-Onset vs. Late-Onset Sepsis & Maternal GBS Management 11.2 Infection Prevention, CLABSI Bundles & Antimicrobial Stewardship 11.3 Neonatal Pharmacology & High-Alert Medication Administration 11.4 Congenital & Perinatal Infections, Sexually Transmitted Infections and Immune Function 11.5 Vitamin K, Eye Prophylaxis, Immunization & Routine Neonatal Medications
12 Chapter 12: Neurodevelopmental Care, Family-Centered Care & Discharge Transition
12.1 Developmental Care, Stress Reduction & Non-Pharmacologic Pain Management 12.2 Neonatal Abstinence Syndrome (NAS/NOWS) & Eat, Sleep, Console (ESC) 12.3 Discharge Readiness, Car Seat Challenge & Safe Sleep Education 12.4 Psychosocial Support, Family Adaptation & Perinatal Grief 12.5 Home Care Technology, Developmental Follow-Up & Community Referral
13 Chapter 13: Professional Issues, Safety, Quality & Ethics in Neonatal Nursing
13.1 Patient Safety, Error Prevention & Quality Improvement 13.2 Bioethics, Legal Standards & Family Advocacy
14 Chapter 14: Musculoskeletal, Integumentary & Birth Injury Conditions
14.1 Musculoskeletal Anomalies & Neonatal Birth Injuries 14.2 Neonatal Skin: Barrier Physiology, Normal Variations & Common Lesions
11.5 Vitamin K, Eye Prophylaxis, Immunization & Routine Neonatal Medications
Key Takeaways Explain This Topic AI
Every newborn is functionally vitamin K deficient because vitamin K crosses the placenta poorly, the gut is sterile at birth, breast milk is low in vitamin K, and the immature liver carboxylates factors II, VII, IX, and X inefficiently — so prophylaxis is a single 1 mg intramuscular injection into the vastus lateralis within 6 hours of birth for infants over 1,500 g, and 0.3 to 0.5 mg/kg for infants weighing 1,500 g or less.
Late vitamin K deficiency bleeding occurs from 1 week to 6 months with a peak at 2 to 8 weeks, occurs almost exclusively in unprophylaxed exclusively breastfed infants, and presents as intracranial hemorrhage in 30 to 60% of cases, which is why oral regimens are considered inferior.
Erythromycin ophthalmic ointment prevents gonococcal ophthalmia but not chlamydial conjunctivitis; silver nitrate is no longer used because it caused chemical conjunctivitis.
Preterm infants are immunized by chronological age at full dose and vaccines are never deferred to corrected age; the sole routine exception is the hepatitis B birth dose in an infant under 2,000 g born to an HBsAg-negative mother, which is delayed to 1 month or discharge.
Oral sucrose 24% works only because its analgesic effect is taste-mediated, so it must reach the anterior tongue about 2 minutes before a painful procedure and is useless when instilled through a gastric tube.
Last updated: August 2026
11.5 Vitamin K, Eye Prophylaxis, Immunization & Routine Neonatal Medications
Clinical Pearl & Core Takeaway: The NCC blueprint's pharmacology heading opens its list of common drugs used in neonates with Vitamin K , then eye prophylaxis, vaccines, immunologic agents, diuretics, bronchodilators, and supplements. These are the medications a Level I/II nurse gives on every shift, to every baby — and precisely because they are routine, they are where refusal conversations, dosing errors, and missed windows actually happen.
- 1. Vitamin K Prophylaxis and Vitamin K Deficiency Bleeding
- Why every newborn needs it
Vitamin K is the cofactor for hepatic gamma-carboxylation of clotting factors II, VII, IX, and X plus proteins C and S. Every newborn is functionally vitamin K deficient at birth for four converging reasons:
Vitamin K crosses the placenta poorly , so fetal stores are minimal.
The gut is sterile at birth , so there is no bacterial synthesis of vitamin K2.
Breast milk is low in vitamin K (formula is fortified — which is why late VKDB is overwhelmingly a disease of exclusively breastfed infants).
The immature liver produces the clotting factors inefficiently.
The dose
Infants weighing > 1,500 g: a single 1 mg intramuscular dose within 6 hours of birth , into the vastus lateralis .
Infants weighing ≤ 1,500 g: 0.3 to 0.5 mg/kg as a single intramuscular dose.
The three presentations of VKDB
Type Timing Typical Setting Presentation
Early < 24 hours Maternal medications that impair vitamin K metabolism — anticonvulsants (phenytoin, phenobarbital, carbamazepine), rifampin and other antituberculars, warfarin, and some antibiotics Cephalohematoma, intracranial, intra-abdominal, and gastrointestinal bleeding
Classic Day 2 to day 7 Most cases idiopathic; inadequate intake Gastrointestinal bleeding, bleeding from the umbilical stump, circumcision site, or puncture sites; bruising
Late 1 week to 6 months, peaking at 2 to 8 weeks Exclusively breastfed infants who did not receive prophylaxis ; also cholestasis and malabsorption Intracranial hemorrhage in 30% to 60% of cases — this is the type that kills and disables
Handling refusal
Parental declination is rising, and with it the incidence of late VKDB. Oral regimens exist internationally but are less effective , particularly against late VKDB, and require multiple doses with poor adherence. When parents decline:
Explain concretely: late VKDB has no warning signs, and roughly half of cases present as bleeding into the brain.
Distinguish clearly for them that this is not a vaccine and contains no live or infectious material.
Document the discussion, the education provided, and the decision.
Ensure the declination is communicated to the primary care provider and clearly flagged in the record , because any subsequent bleeding, lethargy, pallor, or seizure in that infant must be treated as VKDB until proven otherwise.
Circumcision should not proceed without prophylaxis.
2. Ocular Prophylaxis
Erythromycin 0.5% ophthalmic ointment : a 1 cm ribbon into each lower conjunctival sac , applied within about the first hour of life. Administration may be briefly delayed to support initial bonding and breastfeeding, but should not be omitted.
Technique: apply from the inner canthus outward, do not rinse it away, and do not touch the tube tip to the eye. Some transient chemical irritation is expected.
Silver nitrate is no longer used in the United States because it produced a marked chemical conjunctivitis.
The critical limitation, repeated because it is heavily tested: prophylaxis prevents gonococcal ophthalmia but NOT chlamydial conjunctivitis.
Prophylaxis is legally mandated in most states , which is why refusal requires a documented conversation and, in many jurisdictions, specific paperwork.
- 3. Immunization and Immunologic Agents
- Hepatitis B vaccine — the birth dose
Maternal HBsAg Status Action
Negative Hepatitis B vaccine within 24 hours for medically stable infants weighing ≥ 2,000 g . For infants < 2,000 g , delay the dose to 1 month of age or hospital discharge, because the immune response at very low weight is poor
Positive Vaccine AND hepatitis B immune globulin (HBIG) within 12 hours, at two separate injection sites , regardless of birth weight. For infants < 2,000 g the birth dose does not count toward the series
- Unknown Vaccine within 12 hours ; test the mother urgently and add HBIG if positive
- The rule that catches people out: preterm infants are immunized by CHRONOLOGICAL age
A 26-week infant who is 2 months old receives the full standard 2-month vaccine series at full dose , even though corrected age is still well below term. Vaccines are never deferred to corrected age and doses are never reduced. The only routine exception is the hepatitis B birth dose in an infant under 2,000 g born to an HBsAg-negative mother. Under-immunization of former preterm infants is a real and preventable harm, because these are exactly the infants for whom pertussis and pneumococcal disease are most dangerous.
RSV immunoprophylaxis
Nirsevimab , a long-acting monoclonal antibody, is given as a single intramuscular dose to infants under 8 months born during or entering their first RSV season — typically 50 mg for infants under 5 kg and 100 mg for infants 5 kg and over .
It is not indicated when the mother received the maternal RSVpreF vaccine at 32 to 36 weeks at least 14 days before delivery and the infant is otherwise healthy; it is indicated when maternal vaccination did not occur, is unknown, or occurred within 14 days of birth.
Palivizumab remains an option in some settings for high-risk infants and requires monthly dosing throughout the season — a critical parent-teaching point, because a single dose confers no season-long protection.
Other immunologic agents
Hepatitis B immune globulin (HBIG) — as above.
Varicella-zoster immune globulin (VariZIG) — for infants whose mothers develop varicella from 5 days before to 2 days after delivery.
Intravenous immune globulin (IVIG) — used in severe isoimmune hemolytic disease to blunt hemolysis and reduce the need for exchange transfusion.
4. Supplements
Supplement Who and When Notes
Vitamin D 400 IU daily for all breastfed and partially breastfed infants, beginning in the first days of life; formula-fed infants taking less than about 1 litre daily also need it Human milk does not contain adequate vitamin D regardless of maternal intake
Iron Preterm infants: 2 to 4 mg/kg/day , typically begun at 2 to 4 weeks of age and continued through the first year. Exclusively breastfed term infants: about 1 mg/kg/day from 4 months until iron-rich complementary foods are established Preterm infants miss the third-trimester iron accretion. Do not start iron before the physiologic reticulocyte response is under way
Medium-chain triglycerides (MCT) Added for infants with fat malabsorption, cholestasis, chylothorax, or short gut MCT are absorbed directly into the portal circulation and do not require bile salts or lymphatic transport
Human milk fortifier / multivitamins Preterm infants on human milk Covered in detail with nutrition
Probiotics Not routinely recommended Although meta-analyses show reduced necrotizing enterocolitis, the AAP has not endorsed routine use in preterm infants , citing the absence of an FDA-regulated pharmaceutical-grade product, inconsistent strains and viability across products, and reports of invasive infection with the administered organism , including a fatal case that prompted an FDA safety communication. If a unit uses them, it must be under a defined protocol with a known product and strain
5. Diuretics, Bronchodilators and Other Common Agents
Drug Class Agent & Typical Use Key Nursing Considerations
Loop diuretic Furosemide ~1 mg/kg, for fluid overload and symptomatic patent ductus arteriosus or chronic lung disease Ototoxicity is synergistic with aminoglycosides — never give with gentamicin without discussion. Causes hypokalemia, hyponatremia, hypochloremic metabolic alkalosis, and hypercalciuria leading to nephrocalcinosis with chronic use. Monitor electrolytes and urine output
Thiazide + potassium-sparing Chlorothiazide with spironolactone , for chronic lung disease Gentler and preferred for long-term use; still monitor electrolytes
Bronchodilator Albuterol by nebulizer, occasionally in established bronchopulmonary dysplasia Benefit in neonates is limited and transient; watch for tachycardia and tremor. Not a treatment for RDS or TTN
Antifungal Nystatin oral suspension for thrush; topical nystatin for candidal diaper dermatitis Swab all oral surfaces after feeds and let it remain in contact; treat the mother's nipples concurrently in a breastfeeding dyad or the pair will reinfect each other
Non-pharmacologic analgesic 24% oral sucrose , 0.5 to 2 mL onto the anterior tongue about 2 minutes before a painful procedure, ideally with a pacifier The analgesic effect is mediated by taste-triggered endogenous opioid release, so it must reach the tongue , not the stomach — never give it through a gastric tube
Naloxone No longer recommended in the delivery room NRP removed it from neonatal resuscitation. It can precipitate seizures in an infant of an opioid-dependent mother. Respiratory depression is managed with ventilation
6. Safe Administration of Routine Medications
Routine does not mean low-risk. Three habits prevent most of the harm:
Independent double-check every parenteral dose, including vitamin K. The dose is 1 mg — not 1 mL, and not 0.1 mg. A vitamin K wrong-dose event is a documented sentinel event.
Confirm the injection site. Neonatal intramuscular injections go into the vastus lateralis , never the dorsogluteal site, because the gluteal muscle is undeveloped and the sciatic nerve is close to the surface.
Verify the window. Vitamin K within 6 hours; eye prophylaxis within the first hour; hepatitis B vaccine and HBIG within 12 hours when the mother is HBsAg-positive. Each of these has a defined deadline, and a missed deadline is a reportable variance — not a rounding error.